Pharmaceutical promotion and GP prescription behaviour

Pharmaceutical promotion and GP prescription behaviour.

The aim of this paper is to empirically analyse the responses by general practitioners to promotional activities for ethical drugs by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be harmful in the sense that it lowers price sensitivity of doctors and it merely is a means of maintaining market share, even when cheaper, therapeutically...

Measuring Prescription Adherence for Pharmaceutical Prescription Refills

Pharmaceutical Arithmetic and Latin Including Prescription Reading

GP reimbursement and visiting behaviour in Ireland.

In Ireland, approximately 30% of the population receive free GP services (medical card patients) while the remainder (private patients) must pay for each visit. In 1989, the manner in which GPs were reimbursed by the State for their medical card patients was changed from fee-for-service to capitation while private patients continued to pay on a fee-for-service basis. Concerns about supplier-ind...

Covert pharmaceutical promotion in free medical journals.

534 CMAJ, March 22, 2011, 183(5) © 2011 Canadian Medical Association or its licensors The influence of the promotional practices of pharmaceutical manufacturers on the prescribing behaviour of physicians has long been recognized. Since the early 1980s, studies of this phenomenon have repeatedly shown that physicians’ knowledge of drug properties is more consistent with sales information than wi...